BIOVANT Trademark

Trademark Overview

On Tuesday, July 29, 2008, a trademark application was filed for BIOVANT with the United States Patent and Trademark Office. The USPTO has given the BIOVANT trademark a serial number of 77533337. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 15, 2012. This trademark is owned by BioSante Pharmaceuticals, Inc.. The BIOVANT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, nanoparticle vaccines and nanoparticle vaccine adjuvants
biovant

General Information

Serial Number77533337
Word MarkBIOVANT
Filing DateTuesday, July 29, 2008
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 15, 2012
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 23, 2009

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, nanoparticle vaccines and nanoparticle vaccine adjuvants
Pseudo MarkBIOSANTE VANT

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 1, 2008
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBioSante Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLincolnshire, IL 60069
Party NameBioSante Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLincolnshire, IL 60069

Trademark Events

Event DateEvent Description
Monday, October 15, 2012ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, October 15, 2012ABANDONMENT - NO USE STATEMENT FILED
Thursday, March 15, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 14, 2012EXTENSION 5 GRANTED
Tuesday, March 13, 2012EXTENSION 5 FILED
Tuesday, March 13, 2012TEAS EXTENSION RECEIVED
Thursday, September 15, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 14, 2011EXTENSION 4 GRANTED
Monday, September 12, 2011EXTENSION 4 FILED
Monday, September 12, 2011TEAS EXTENSION RECEIVED
Friday, March 11, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 10, 2011EXTENSION 3 GRANTED
Tuesday, March 8, 2011EXTENSION 3 FILED
Tuesday, March 8, 2011TEAS EXTENSION RECEIVED
Tuesday, October 5, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 4, 2010EXTENSION 2 GRANTED
Monday, September 13, 2010EXTENSION 2 FILED
Monday, October 4, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, September 13, 2010TEAS EXTENSION RECEIVED
Friday, February 12, 2010EXTENSION 1 GRANTED
Friday, February 12, 2010EXTENSION 1 FILED
Friday, February 12, 2010TEAS EXTENSION RECEIVED
Tuesday, September 15, 2009NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 23, 2009PUBLISHED FOR OPPOSITION
Wednesday, June 3, 2009NOTICE OF PUBLICATION
Friday, May 15, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, May 14, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 12, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 11, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 12, 2009ASSIGNED TO LIE
Monday, May 11, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, November 9, 2008NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, November 9, 2008NON-FINAL ACTION E-MAILED
Sunday, November 9, 2008NON-FINAL ACTION WRITTEN
Thursday, November 6, 2008ASSIGNED TO EXAMINER
Saturday, August 2, 2008NOTICE OF PSEUDO MARK MAILED
Friday, August 1, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

biovant nanoparticle vaccine adjuvants vaccines pharmaceutical namely preparations